首页> 外文期刊>Internal medicine. >Severe Hyponatremia in Association with I131 Therapy in a Patient with Metastatic Thyroid Cancer
【24h】

Severe Hyponatremia in Association with I131 Therapy in a Patient with Metastatic Thyroid Cancer

机译:转移性甲状腺癌患者的严重低钠血症与I131治疗相关

获取原文
获取外文期刊封面目录资料

摘要

Hyponatremia is a common clinical problem that results from various causes. Hypothyroidism is known to be one of the causes of this disorder. We report a case of metastatic thyroid cancer presenting with severe hyponatremia in association with hypothyroidism induced by pretreatment of I131 therapy, such as a low-iodine diet and withdrawal of thyroid hormone. Serum arginine vasopressin (AVP) was elevated and urine osmolality was higher than that of serum. Saline infusion and thyroid hormone replacement normalized serum sodium and AVP. Inappropriate secretion of AVP in hypothyroid state was thought to be one of the causes of this hyponatremia.
机译:低钠血症是由多种原因引起的常见临床问题。甲状腺功能减退症是导致这种疾病的原因之一。我们报告了一例转移性甲状腺癌,该病例因I 131 疗法(如低碘饮食和甲状腺激素停药)的预处理而引起的严重低钠血症并伴有甲状腺功能低下。血清精氨酸加压素(AVP)升高,尿渗透压高于血清。盐水输注和甲状腺激素替代使血清钠和AVP正常化。甲状腺功能减退状态下AVP分泌不当被认为是造成这种低钠血症的原因之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号